Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker...

Por Rasmussen, LJH, Knudsen, A, Katzenstein, TL, Gerstoft, J, Obel, N, Jørgensen, NR, Kronborg, G, Benfield, T, Kjær, A, Eugen‐Olsen, J, Lebech, A‐M
Publicado no HIV Med (2015)

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis

Por Gustafsson, Anna, Ljunggren, Lennart, Bodelsson, Mikael, Berkestedt, Ingrid
Publicado em 2012

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls

Por Peter Jirak, Rudin Pistulli, Michael Lichtenauer, Bernhard Wernly, Vera Paar, Lukas J. Motloch, Richard Rezar, Christian Jung, Uta C. Hoppe, P. Christian Schulze, Daniel Kretzschmar, Rüdiger C. Braun-Dullaeus, Tarek Bekfani
Publicado em 2020-04-01

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection

Por Rabensteiner, Jasmin, Prüller, Florian, Prattes, Jürgen, Valentin, Thomas, Zollner-Schwetz, Ines, Krause, Robert, Hoenigl, Martin
Publicado no GMS Infect Dis (2016)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection

Por Rabensteiner, Jasmin, Prüller, Florian, Prattes, Jürgen, Valentin, Thomas, Zollner-Schwetz, Ines, Krause, Robert, Hoenigl, Martin
Publicado em 2016-07-01

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients

Por Khater, Walaa S., Salah-Eldeen, Noha N., Khater, Mohamed S., Saleh, Asghraf N.
Publicado no Eur J Microbiol Immunol (Bp) (2016)

Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non...

Por Lomholt, A F, Høyer-Hansen, G, Nielsen, H J, Christensen, I J
Publicado em 2009

Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study

Por Luo, Qiongzhen, Ning, Pu, Zheng, Yali, Shang, Ying, Zhou, Bing, Gao, Zhancheng
Publicado no Crit Care (2018)

The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders

Por Vasarhelyi, Barna, Toldi, Gergely, Balog, Attila
Publicado no EJIFCC (2016)

SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue...

Por Polzik, Peter, Grøndal, Olav, Tavenier, Juliette, Madsen, Martin B., Andersen, Ove, Hedetoft, Morten, Hyldegaard, Ole
Publicado no Sci Rep (2019)

Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy

Por Ivancsó, István, Toldi, Gergely, Bohács, Anikó, Eszes, Noémi, Müller, Veronika, Rigó, János, Vásárhelyi, Barna, Losonczy, György, Tamási, Lilla
Publicado em 2013

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer

Por Rasmussen, Line Jee Hartmann, Schultz, Martin, Gaardsting, Anne, Ladelund, Steen, Garred, Peter, Iversen, Kasper, Eugen‐Olsen, Jesper, Helms, Morten, David, Kim Peter, Kjær, Andreas, Lebech, Anne‐Mette, Kronborg, Gitte
Publicado no Int J Cancer (2017)

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease...

Por Rasmussen, Line Jee Hartmann, Ladelund, Steen, Haupt, Thomas Huneck, Ellekilde, Gertrude, Poulsen, Jørgen Hjelm, Iversen, Kasper, Eugen-Olsen, Jesper, Andersen, Ove
Publicado no Emerg Med J (2016)

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index...

Por Haupt, Thomas Huneck, Petersen, Janne, Ellekilde, Gertrude, Klausen, Henrik Hedegaard, Thorball, Christian Wandall, Eugen-Olsen, Jesper, Andersen, Ove
Publicado em 2012

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR...

Por Rasmussen, Line J. H., Ladelund, Steen, Haupt, Thomas H., Ellekilde, Gertrude E., Eugen-Olsen, Jesper, Andersen, Ove
Publicado no Crit Care Med (2018)

Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure

Por Jirak, Peter, Fejzic, Dzeneta, Paar, Vera, Wernly, Bernhard, Pistulli, Rudin, Rohm, Ilonka, Jung, Christian, Hoppe, Uta C, Schulze, P Christian, Lichtenauer, Michael, Yilmaz, Atilla, Kretzschmar, Daniel
Publicado no Acta Pharmacol Sin (2017)

Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers

Por Marazzi, Monica Gioia, Randelli, Filippo, Brioschi, Marco, Drago, Lorenzo, Romanò, Carlo Luca, Banfi, Giuseppe, Massaccesi, Luca, Crapanzano, Calogero, Morelli, Franca, Corsi Romanelli, Massimiliano Marco, Galliera, Emanuela
Publicado no Int J Immunopathol Pharmacol (2017)

Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial Infarction

Por Sörensen, Nils A., Dönmez, Günay, Neumann, Johannes T., Nikorowitsch, Julius, Rübsamen, Nicole, Blankenberg, Stefan, Westermann, Dirk, Zeller, Tanja, Karakas, Mahir
Publicado no Biomolecules (2019)

Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective...

Por Gu, Qiu-hua, Cui, Zhao, Huang, Jing, Zhang, Yi-Miao, Qu, Zhen, Wang, Fang, Wang, Xin, Wang, Su-xia, Liu, Gang, Zhao, Ming-hui
Publicado no Medicine (Baltimore) (2016)

Risk assessment models for potential use in the emergency department have lower predictive ability in older patients compared to the middle-aged for short-term mortality – a retrospective cohort study

Por Schultz, Martin, Rasmussen, Line Jee Hartmann, Carlson, Nicolas, Hasselbalch, Rasmus Bo, Jensen, Birgitte Nybo, Usinger, Lotte, Eugen-Olsen, Jesper, Torp-Pedersen, Christian, Rasmussen, Lars Simon, Iversen, Kasper Karmark
Publicado no BMC Geriatr (2019)